Company Profile
Updated: 23-SEP-09BioMarker Pharmaceuticals Inc.
Private Company, Headquarters Location
5941 Optical Ct., San Jose, CA 95138-1400, United States
(408)257-2000, (408)356-6661 fax, http://www.biomarkerinc.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Drug development focusing on mechanisms underlying aging and age-related diseases.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
NuGEN Enters the Next Generation Sequencing Arena With the Ovation[R] RNA-Seq System.
Genomics & Genetics Weekly; 12/18/2009; 1029 words; ...NuGEN Technologies, Inc., a pace-setter...NuGEN Technologies, Inc). Ovation is the...for larger-scale biomarker discovery projects...Genomics, Health, Pharmaceutical, RNA Research, NuGEN Technologies Inc. This article was...
CRi Announces Results of Signaling Pathway Protein Study.(Clinical report)
Blood Weekly; 12/17/2009; 1376 words; ...Research & Instrumentation, Inc. (CRi), a leader...technologies in clinical biomarker analysis for developing...http://www.cri-inc.com/files/CRi...Learn more at www.cri-inc.com. About Cell Signaling...Oncology, Other Health, Pharmaceutical, Pharmaceut
Reports from University catholique of Louvain add new data to research in chronic lymphocytic leukemia therapy.(Report)
Blood Weekly; 12/17/2009; 1321 words; ...frequently altered. We identified a novel biomarker of chemosensitivity based on the induction...Haematology is: Blackwell Publishing Inc., 350 Main St., Malden, MA 02148...Neurology, Nucleoside Analog, Oncology, Pharmaceuticals, Therapy, Treatment. This article...
Clarient Granted Exclusive License to Commercialize Cancer Biomarker by Minerva Biotechnologies.
Cancer Weekly; 12/15/2009; 1205 words; Clarient, Inc. (NASDAQ:CLRT...oncologists and the pharmaceutical industry, announced...MUC1* protein, a biomarker researchers believe...see also Clarient, Inc.; Minerva Biotechnologies...Oncology, Pathology, Pharmaceuticals, Solid Cancers, Solid...s Health, Clarient Inc.; Minerva ...
Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman.
Cancer Weekly; 12/8/2009; 978 words; ...Discovery, Inc., which...appointment of pharmaceutical industry...Synaptic Pharmaceuticals and Archemix...development of biomarker and pharmacogenomic...Synaptic Pharmaceuticals and Archemix, Inc) and experience...with large pharmaceutical companies...Oncology, ...
Recent News Articles
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning